Isabelle Boutron

发表

Additional file 1: of A scoping review on the roles and tasks of peer reviewers in the manuscript review process in biomedical journals

David Moher, Ketevan Glonti, Daniel Cauchi, 2019 .

Consolidated Standards of Reporting Trials (CONSORT) extensions covered most types of randomized controlled trials, but the potential workload for authors was high

Isabelle Boutron, Lina Ghosn, Philippe Ravaud, 2019, Journal of Clinical Epidemiology.

Additional file 4: of A scoping review on the roles and tasks of peer reviewers in the manuscript review process in biomedical journals

David Moher, Ketevan Glonti, Daniel Cauchi, 2019 .

Additional file 3: of A scoping review on the roles and tasks of peer reviewers in the manuscript review process in biomedical journals

David Moher, Ketevan Glonti, Daniel Cauchi, 2019 .

Splint for Base-of-Thumb Osteoarthritis

Isabelle Boutron, Philippe Ravaud, Franois Rannou, 2009, Annals of Internal Medicine.

69 Automating the process of systematic reviews in healthcare research – a methodological systematic review

Isabelle Boutron, Razia Aliani, Nicole Pitcher, 2019 .

Tools used to assess the quality of peer review reports: a methodological systematic review

Erik Cobo, Isabelle Boutron, Darko Hren, 2019, BMC Medical Research Methodology.

Future of evidence ecosystem series: 2. Current opportunities and need for better tools and methods.

Isabelle Boutron, Philippe Ravaud, Hywel Williams, 2020, Journal of clinical epidemiology.

RoB 2: a revised tool for assessing risk of bias in randomised trials

Natalie S Blencowe, Christopher J Cates, Isabelle Boutron, 2019, BMJ.

Node-making process in network meta-analysis of nonpharmacological treatment are poorly reported.

Isabelle Boutron, Philippe Ravaud, Arthur James, 2017, Journal of clinical epidemiology.

Additional file 2: of A scoping review on the roles and tasks of peer reviewers in the manuscript review process in biomedical journals

David Moher, Ketevan Glonti, Daniel Cauchi, 2019 .

Performance of principal scores to estimate the marginal compliers causal effect of an intervention

Isabelle Boutron, Raphaël Porcher, Gabriel Baron, 2016, Statistics in medicine.

Importance of the methods used to support the node-making process in network meta-analysis.

Isabelle Boutron, Arthur James, Amélie Yavchitz, 2018, Journal of clinical epidemiology.

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

Kristian Thorlund, David Moher, Chris Cameron, 2015, Annals of Internal Medicine.

Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis.

Isabelle Boutron, Philippe Ravaud, Bruno Giraudeau, 2003, JAMA.

Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study

Isabelle Boutron, Philippe Ravaud, Ludovic Trinquart, 2012, BMJ : British Medical Journal.

Factors associated with online media attention to research: a cohort study of articles evaluating cancer treatments

Isabelle Boutron, Lina Ghosn, Philippe Ravaud, 2017, Research integrity and peer review.

Challenges in evaluating surgical innovation

Jane M Blazeby, Isabelle Boutron, Jonathan A Cook, 2009, The Lancet.

Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments

David Moher, Isabelle Boutron, Philippe Ravaud, 2007, PLoS medicine.

The statistical significance of meta-analyses is frequently fragile: definition of a fragility index for meta-analyses.

Isabelle Boutron, Philippe Ravaud, Raphaël Porcher, 2019, Journal of clinical epidemiology.

Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials

Sihem Amer-Yahia, Emmanuel Coquery, Mohand-Said Hacid, 2020, Journal of Clinical Epidemiology.

CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.

David Moher, Douglas G Altman, Isabelle Boutron, 2017, Annals of internal medicine.

Geographical Representativeness of Published and Ongoing Randomized Controlled Trials. The Example of: Tobacco Consumption and HIV Infection

Isabelle Boutron, Philippe Ravaud, Pierre Durieux, 2011, PloS one.

Misrepresentation of Randomized Controlled Trials in Press Releases and News Coverage: A Cohort Study

Isabelle Boutron, Philippe Ravaud, Amélie Yavchitz, 2012, PLoS medicine.

Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study

Gary S Collins, Sally Hopewell, Douglas G Altman, 2014, BMJ : British Medical Journal.

Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial

Douglas G Altman, Isabelle Boutron, Philippe Ravaud, 2015, BMC Medicine.

Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge.

David Moher, Douglas G Altman, Isabelle Boutron, 2013, The Cochrane database of systematic reviews.

Descriptions of non-pharmacological interventions in clinical trials

Isabelle Boutron, Andrew Cook, I. Boutron, 2013, BMJ : British Medical Journal.

Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.

David Moher, Douglas G Altman, Isabelle Boutron, 2008, Annals of internal medicine.

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study

David Moher, Douglas G Altman, Isabelle Boutron, 2017, British Medical Journal.

Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.

Isabelle Boutron, Philippe Ravaud, Bruno Giraudeau, 2004, Journal of clinical epidemiology.

Impact of searching clinical trial registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analyses

Isabelle Boutron, Philippe Ravaud, Amélie Yavchitz, 2017, British Medical Journal.

A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity.

David Moher, Douglas G Altman, Isabelle Boutron, 2016, Journal of clinical epidemiology.

Misrepresentation and distortion of research in biomedical literature

Isabelle Boutron, Philippe Ravaud, I. Boutron, 2018, Proceedings of the National Academy of Sciences.

Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic Study

Isabelle Boutron, Philippe Ravaud, Ludovic Trinquart, 2011, Annals of Internal Medicine.

Classification and prevalence of spin in abstracts of non-randomized studies evaluating an intervention

Isabelle Boutron, Philippe Ravaud, Romana Haneef, 2015, BMC Medical Research Methodology.

Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.

Douglas G Altman, Isabelle Boutron, Philippe Ravaud, 2010, JAMA.

A revised tool for assessing risk of bias in randomized trials

Isabelle Boutron, Julian P T Higgins, Jonathan A C Sterne, 2016 .

Comparison of registered and published primary outcomes in randomized controlled trials.

David Moher, Douglas G Altman, Isabelle Boutron, 2009, JAMA.

The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration

David Moher, Douglas G Altman, Isabelle Boutron, 2013, Systematic Reviews.

Increasing value and reducing waste in biomedical research: who's listening?

David Moher, Isabelle Boutron, Philippe Ravaud, 2016, The Lancet.

Reporting of safety results in published reports of randomized controlled trials.

Isabelle Boutron, Philippe Ravaud, I. Boutron, 2009, Archives of internal medicine.

Reducing waste from incomplete or unusable reports of biomedical research

David Moher, Elizabeth Wager, Douglas G Altman, 2014, The Lancet.

Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional study

Sally Hopewell, Douglas G Altman, Isabelle Boutron, 2013, BMJ Open.

The most important tasks for peer reviewers evaluating a randomized controlled trial are not congruent with the tasks most often requested by journal editors

Isabelle Boutron, Philippe Ravaud, Gabriel Baron, 2015, BMC Medicine.

University of Southern Denmark Systematic review adherence to methodological or reporting quality

Douglas G. Altman, David Moher, Isabelle Boutron, 2017 .

Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis

Sally Hopewell, Isabelle Boutron, Philippe Ravaud, 2012, BMJ : British Medical Journal.

Association between trial registration and treatment effect estimates: a meta-epidemiological study

Isabelle Boutron, Philippe Ravaud, Ignacio Atal, 2016, BMC Medicine.

Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial.

Sally Hopewell, Douglas G Altman, Isabelle Boutron, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals

Isabelle Boutron, Philippe Ravaud, Romana Haneef, 2013, PLoS medicine.

Deficiencies in the publication and reporting of the results of systematic reviews presented at scientific medical conferences.

Sally Hopewell, Douglas G Altman, Isabelle Boutron, 2015, Journal of clinical epidemiology.

Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews

Isabelle Boutron, Jelena Savović, Jonathan A. C. Sterne, 2016, Systematic Reviews.

A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus.

David Moher, Isabelle Boutron, Philippe Ravaud, 2005, Journal of clinical epidemiology.

Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors

Isabelle Boutron, Philippe Ravaud, Ann Sofia Skou Thomsen, 2012, BMJ : British Medical Journal.

Taking healthcare interventions from trial to practice

Sophie Hill, Douglas G Altman, Isabelle Boutron, 2010, BMJ : British Medical Journal.

Review and publication of protocol submissions to Trials – what have we learned in 10 years?

Douglas G. Altman, Jeremy M. Grimshaw, Erik Cobo, 2016, Trials.